Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Exposure to beta particles emitted by radioactive iodine-131 leads to ionization events in living tissue, producing free radicals and causing direct and indirect DNA damage—principally single-strand and double-strand breaks[1][2][3][4]. This damage, if unrepaired, results in cell death via apoptosis or necrosis, a process harnessed therapeutically to treat conditions such as thyroid cancer and hyperthyroidism[3][4]. However, this is not a protein, receptor, or otherwise canonical therapeutic target, but a description of the radiobiological effects of iodine-131 therapy on DNA integrity.
Induction of DNA single-strand and double-strand breaks by beta particles emitted from iodine-131 decay, leading to cell death if damage is unrepaired or misrepaired Free radical generation via ionization, further damaging DNA molecules
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ionizing radiation-induced DNA damage by beta emission from iodine-131.